最近の記事
2024/07/05
2024/05/14
2024年2月14日(水)における次世代ゼブラフィッシュ創薬・研究開発セミナー
2024/05/08
2024/05/02
2024/05/01
high-throughput individual zebrafish screening
2024/04/26
2024/04/25
discovery of stanniocalcin1 as cardiotoxic defence gene
2024/04/24
Tumour Angiogenesis in Patient-Deriveved Xenograft Zebarafish Model
2024/04/23
Aging-associated microstructural deterioration of vertebra in zebra fi sh
2024/04/23
Aging-associated microstructural deterioration of vertebra in zebra fi sh
discovery of stanniocalcin1 as cardiotoxic defence gene
We have discovered stanniocalcin1 as cardiotoxic defence gene in 2015. the potential clinical applications of stanniocalcin in oncocardiology include its use as a biomarker for cancer therapy-induced cardiotoxicity, its potential as a therapeutic target for cardioprotection, and its role in regulating calcium homeostasis, which may be relevant for managing calcium-related cardiovascular complications in cancer patients.
関連ファイル
discovery of stanniocalcin1 as cardiotoxic defence gene
high-throughput screening for cardiotoxicology
関連リンク